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Systemic lupus erythematosus (SLE) is an autoimmune disease that can involve any organ system, exhibiting great
diversity in presentation. Cardiac tamponade as the initial presentation of childhood onset SLE (cSLE) is rare. We
report the case of a 10 year old Afro-Caribbean female who presented with complaints of chest pain, shortness of
breath and fever over 4 days. Clinical examination strongly suggested cardiac tamponade which was confirmed by
investigations and treated with pericardiocentesis. After a thorough investigation, the underlying diagnosis of SLE
was confirmed using the Systemic Lupus International Collaborating Clinics (SLICC) criteria and high dose corticosteroid
therapy initiated. A review of recent studies shows that common initial presentations of cSLE include constitutional
symptoms, renal disease, musculoskeletal and cutaneous involvement. In presenting this case and reviewing the literature
we emphasize the importance of cSLE as a differential diagnosis when presented with pericarditis in the presence
or absence of cardiac tamponade. In these patients early diagnosis and treatment is desired and in this regard we
also discuss the sensitivity of the SLICC criteria in cSLE.
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Systemic lupus erythematosus (SLE) is an autoimmune
disease that can involve any organ system resulting in a
great diversity of clinical presentation. Approximately
20% of cases present in childhood. The estimated inci-
dence of childhood onset systemic lupus erythematosus
(cSLE) has been reported as 0.28 to 2.22 per 100,000
children and prevalence 6.3 - 9.73 per 100,000 children,
with higher frequencies in non-Caucasian populations
[1-3]. Pericarditis and pericardial effusions in SLE are
well recognized in SLE. Cardiac tamponade is a medical
emergency that develops when a pericardial effusion
reaches a critical amount, limiting cardiac inflow and
leading to hemodynamic compromise. In this case report
we present and discuss pericarditis leading to cardiac
tamponade as the initial manifestation of cSLE.* Correspondence: satishsmaharaj@gmail.com
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article, unless otherwise stated.Case presentation
A 10 year old girl of Afro-Caribbean descent presented
to the emergency department with complaints of chest
pain, shortness of breath and fever over the past 4 days.
The left-sided chest pain was described as “squeezing,”
and was associated with palpitations. Both the pain and
shortness of breath were worse in the supine position
and partially relieved on leaning forward. She had no
past medical history. However, over the last three
months she was becoming increasingly fatigued and no-
ticed significant weight loss, intermittent fevers and
arthralgia affecting the wrist and elbow joints. She de-
nied hair loss, oral ulcers, a rash or any medication use.
There was no known family history of autoimmune
disease.
On examination she had a heart rate of 135 bpm, a
respiratory rate of 40 breaths/min, blood pressure of
93/63 mmHg and a temperature of 37.7°C. She was
underweight with a body mass index of 13.8 kg/m2, had
pale conjunctivae and maintained an oxygen saturation
of 98% on room air. On cardiovascular examination
heart sounds were muffled and the apex beat wasCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 2 Posteroanterior chest radiograph at presentation revealed
a markedly enlarged cardiac silhouette and a left-sided
pulmonary infiltrate.
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on inspiration. It was difficult to formally assess for pulsus
paradoxus due to the patient’s abnormal respiration. Jugu-
lar venous distension was evident. Respiratory examin-
ation revealed decreased breath sounds at the left lung
base which was also dull on percussion. The rest of the
examination only proved significant for generalized lymph-
adenopathy. There was no evidence of joint inflammation,
peripheral oedema or clubbing.
Electrocardiography showed sinus tachycardia, low
voltage and electrical alternans [Figure 1, Additional file
1]. The chest radiograph displayed an enlarged cardiac sil-
houette with a left-sided pulmonary infiltrate [Figure 2].
Transthoracic echocardiography confirmed features of
cardiac tamponade from a large circumferential pericar-
dial effusion, along with mobile intrapericardial fibrinous
strands and the pleural effusion [Figures 3 and 4].
Echocardiography guided pericardiocentesis was then
performed and 1000 mL of pericardial fluid was drained,
immediately bringing relief to the patient. Repeat echo-
cardiography showed a reduced volume of pericardial
fluid with no additional reaccumulation and normal
heart function.
Laboratory investigations revealed a normocytic an-
aemia with a normal white cell count and differential.
Erythrocyte sedimentation rate (ESR) was 91 mm/hr and
C-reactive protein (CRP) was markedly elevated at
191 mg/dL. Cardiac biomarkers, renal and liver function
testing were all normal. Urinalysis was within normal
limits and showed no proteinuria. HIV testing and aFigure 1 Electrical alternans was clearly evidenced by the
alternating amplitude of the QRS complexes (arrows).Mantoux tuberculin skin test were negative. The pa-
tient’s serum tested strongly positive for antinuclear anti-
bodies (ANA) with a coarse speckled pattern and was
also positive for anti-double stranded DNA antibodies
(anti-dsDNA). Serum complement levels were low with
a C3 of 36 mg/dL (normal range 101 – 186 mg/dL) and
C4 of 6.7 mg/dL (normal range 16 – 47 mg/dL). Pericar-
dial fluid cytology showed cells of an inflammatory re-
sponse with no microorganisms identified on Gram
stain or Ziehl-Neelsen stain. There was no evidence of
malignancy.
The diagnosis of SLE was established based on the
positive clinical and immunologic findings. The patientFigure 3 Two-dimensional transthoracic echocardiography
visualized a large circumferential pericardial effusion (PE).
Figure 4 Two-dimensional transthoracic echocardiography was
also remarkable for mobile fibrinous strands (arrows) between
the visceral and parietal pericardium, as well as confirmation of
a left-sided pleural effusion (PL).
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laborating Clinics (SLICC) criteria for classifying SLE,
namely serositis, low serum complement levels, positive
serum ANA and positive anti-dsDNA antibodies [4].
Supporting the diagnosis was the history of arthralgia,
generalized lymphadenopathy and elevated ESR. The pa-
tient was started on high dose corticosteroids and dis-
charged soon after with follow up as an outpatient. At
the follow up visit she continued to do well and was en-
rolled in clinic for long term management of cSLE.
Discussion
SLE is one of the most common autoimmune connective
tissue diseases in childhood, where it tends to present
more severely than in adults. Despite this, relatively few
studies have reported on the clinical features of cSLE at
presentation. An understanding of this pattern would
help to reduce the frequently reported diagnostic delayTable 1 Frequency of selected presenting clinical features of
Balkaran et al [5] Spinosa et al. [6] Ab
Country Trinidad Brazil Om
Sample size 33 47 50
Clinical features (%)
Malar rash 36 32 -
Musculoskeletal 70 32 76
Renal disease 64 38 64
Fever 76 34 62
Weight loss -* 26 52
Ulcers - 9 -
Alopecia - 17 36
Pleuritis/ Pleural effusion 9 17 26
Pericarditis/ Pericardial effusion 24 4 22
Neuropsychiatric - 36 18
* denotes no data was presented for that clinical feature.in this age group. Therefore, to better understand the
spectrum of presenting manifestations of cSLE, we ex-
amined six cohorts from different countries that in-
cluded data on pericarditis [5-10]. While acknowledging
the variation in frequencies due to cohort size, patients’
ethnicity and selection biases, certain patterns were
clear. The data (summarized in Table 1) showed that
common initial presentations of cSLE included constitu-
tional symptoms, renal disease, musculoskeletal and cu-
taneous involvement. Less frequently involved at cSLE
presentation were the neuropsychiatric, pulmonary and
cardiac systems, with pericarditis reported in 3–24% of
cases at presentation.
Our patient presented with the non specific symptoms
of positional chest pain and dyspnea on exertion. Exam-
ination revealed tachycardia, tachypnea, hypotension, in-
creased jugular venous pressure and distant heart
sounds, leading to the diagnosis of cardiac tamponade.
Electrocardiography demonstrated sinus tachycardia, elec-
trical alternans (an alternating QRS amplitude with every
other beat) and low voltage, features strongly suggestive of
pericardial effusion and tamponade [11,12]. Chest radiog-
raphy showed an enlarged cardiac silhouette and a left-
sided infiltrate, a combination reported to have a strong
positive predictive value for pericardial effusion [13].
Echocardiography should be performed if possible, not
only because it is the standard to confirm cardiac tam-
ponade [14] but as it can also grade and localize the
pericardial effusion, detect pericardial thickening and
visualize intrapericardial adhesions. In our patient
echocardiography clearly visualized a large circumfer-
ential pericardial effusion with characteristic signs of
tamponade and also confirmed a left-sided pleural
effusion. Within the pericardial effusion, there were
partially attached mobile fibrinous strands traversingchildhood-onset SLE
dwani et al. [7] Hiraki et al. [8] Agarwal et al. [9] Gulay et al. [10]
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visually dramatic feature has been reported in simi-
lar aSLE cases and may be a harbinger of difficult
pericardiocentesis [15-17].
Few studies have examined cardiac involvement in
cSLE and cardiac tamponade in these patients has not
been well-defined. In a 10-year retrospective single cen-
ter study, Oshiro et al. examined 31 patients (<18 years)
diagnosed with cSLE [18]. It was found that 13 patients
(42%) had cardiac involvement and 2 patients presented
with cardiac tamponade (6%). A more recent multicenter
cross-sectional study of 155 cSLE patients (<16 years)
reported the initial manifestation of cardiac tamponade
in 2 cases (1.3%) [19]. This latter figure is consistent
with findings in adult SLE (aSLE) where it is reported
1% of patients present in this way [20]. The much higher
incidence reported by Oshiro et al. was likely influenced
by the composition of their sample which comprised
mainly African-Americans, who are known to have more
severe disease. This however raises the issue of whether
there is a subset of cSLE patients subject to a higher
burden from pericardial disease.
An interesting question is whether cardiac tamponade
is a rare occurrence in cSLE, or rather only rare as the
initial presentation. Pericarditis can occur at any time
during the disease course but appears to be one of the
earlier cardiac manifestations. This is clearly seen in a
longitudinal study of 256 cSLE patients (<18 years)
where out of the 39 patients who had pericarditis at any
time (mean follow-up time 3.5 ± 3 years), 30 patients
presented at diagnosis [8]. However data on the preva-
lence of cardiac tamponade throughout the course of
cSLE is lacking. In one aSLE series of 395 patients, 10
patients were found to have cardiac tamponade and in 4
patients it was the initial manifestation [20]. Therefore
in aSLE it is likely that cardiac tamponade is truly rare,
both as the initial manifestation and throughout the dis-
ease course. Whether this pattern holds true in cSLE is
yet unclear.
We sought to better characterize cardiac tamponade
as the initial presentation of cSLE by performing a re-
view of the literature for patients less than 18 years old.
Including the present case, 15 cases of cardiac tampon-
ade as the initial manifestation of cSLE were identified
using Medline, Scopus, Google Scholar and bibliographies
of relevant articles. Of these, 2 cases were excluded from
analysis; one due to insufficient data [21] and the other
due to possible confounding from growth hormone ther-
apy which was associated with increased risk of immune
disease and lupus flares [22]. The 13 remaining cases of
cSLE presenting with cardiac tamponade were analyzed
and are summarized in Table 2 [17,23-32].
An overwhelming female predominance was noted
with only 1 male patient affected. In 5 cases there was aco-existing pleural effusion which was either left-sided
or present bilaterally [24,25,27]. Co-existing pleuritis
and/or pleural effusion has commonly featured in recent
cases of aSLE presenting with tamponade and outside of
SLE, bilateral pleural effusions in cardiac tamponade are
distinctly rare [33,34]. Hematologic abnormalities were
also frequently found including hemolytic anemia,
thrombocytopenia and leukopenia [17,24,23,28]. Al-
though not tested for in all cases, 5 patients had low
serum complement [17,23,30,31]. This is significant as
a low serum complement C4 level was found to be
predictive of progression to cardiac tamponade in a
series of aSLE patients [35,36]. However, we also note
it has been reported that inherited complement defi-
ciencies are a frequent comorbidity in cSLE [19,37].
Therefore the significance of low serum complement
in these patients would benefit from further research.
The immediate treatment of cardiac tamponade in-
volves withdrawal of pericardial fluid usually by peri-
cardiocentesis, done in all cases except one which was
aborted due to a thickened pericardium with adhesions
[17]. When compared to surgical drainage, echocardiog-
raphy guided pericardiocentesis has been associated with
lower morbidity and mortality rates [38]. Some cases re-
quired placement of a pericardial drain or less com-
monly surgical pericardiectomy. Medical management
consists of anti-inflammatory medication which typically
involves high dose corticosteroids, antimalarials and
non-steroidal anti-inflammatory drugs (Table 2). Follow-
up is essential to exclude recurrent pericardial effusions
and pericardial thickening. In this patient both the
erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP) level were elevated. While an elevated
ESR is common during a flare, CRP is often normal or
mildly elevated. Serositis is one of the few manifestations
of SLE that causes both an elevated CRP level and ESR
[33,39].
The Systemic Lupus International Collaborating Clinics
(SLICC) [4] recently proposed classification criteria ad-
dressing perceived weaknesses of the 1997 American Col-
lege of Rheumatology (ACR) classification criteria [40].
Using the SLICC criteria, our patient was diagnosed with
cSLE. Interestingly, the ACR criteria do not include low
serum complement C3 and/or C4 levels as a relevant im-
munologic criterion. As such, our patient was unable to
fulfil 4 out of the 11 ACR criteria for classifying SLE. In
recent pediatric series, use of the SLICC criteria for the
classification of cSLE, showed better sensitivity and led to
fewer misclassifications, but was less specific than the
ACR criteria [41]. As seen in our patient, low complement
levels have been reported as one of the more frequently
seen immunologic factors found at presentation in cSLE
[41]. The SLICC criteria have also allowed anti-dsDNA
antibodies, anti-Sm antibodies and antiphospholipid
Table 2 Cardiac tamponade as the presenting feature of childhood onset systemic lupus erythematosus
Reference Age
(yrs)
Sex SLICC criteria Treatment
1 Present
case
10 F Serositis, low serum complement, positive ANA and
anti-dsDNA titres.
Pericardiocentesis and oral steroids.
2 Sharda [23] 11 F Serositis, thrombocytopenia, low serum complement,
positive ANA and anti-dsDNA titres.
Pericardiocentesis and oral steroids.
3 Yiallourides
et al. [24]
14 F Hemolytic anemia, serositis, positive ANA and anti-
dsDNA titres.
Pericardial drain insertion, oral steroids, intravenous
methylprednisolone and two cycles of cyclophosphamide.
4 Arabi et al.
[25]
9 M Serositis, nephritis, seizures, elevated ANA and anti-
dsDNA titres.
Pericardiocentesis with pericardial drain insertion,
methylprednisolone pulse therapy followed by oral steroids.
5 Arabi et al.
[25]
11 F Serositis, elevated anti-dsDNA titres. Pericardiocentesis, NSAIDs, oral steroids and antimalarial drugs.
6 Mohseni
et al. [26]
14 F Diagnosed at autopsy; serositis, elevated ANA and
anti-dsDNA titres.
Pericardiocentesis.
7 Kumar et al.
[17]
17 F Serositis, hemolytic anemia, low serum complement,
positive antiphospholipid antibody, positive ANA and
anti-dsDNA titres.
Aborted pericardiocentesis followed by surgical
pericardiectomy, NSAIDs, IV methylprednisolone followed by
oral steroid and antimalarial drugs
8 Saz et al.
[27]
3 F Serositis, positive ANA. Pericardiocentesis and oral steroid.
9 Weich et al.
[28]
15 F Serositis, leukopenia, positive anti-dsDNA titre. Pericardiocentesis with catheter placement, antituberculosis
and oral steroid drugs.
10 Aiuto et al.
[29]
14 F Serositis, nephritis, positive ANA and anti-dsDNA. Pericardiocentesis and oral steroids.
11 Gulati et al.
[30]
8 F Serositis, low serum complement, positive ANA and
anti-dsDNA.
Pericardiocentesis, antituberculosis treatment and oral steroids.
12 Rudra et al.
[31]
14 F Serositis, low serum complement, positive ANA and
anti-dsDNA.
Pericardiocentesis and oral steroids.
13 Lerer [32] 15 F Serositis, nephritis, positive ANA. Pericardiocentesis followed by surgical pericardiectomy and
oral steroids.
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Atypical presentation is common in cSLE and often leads
to major diagnostic delay. By allowing for greater weight-
ing of immunologic criteria the use of the SLICC criteria
may be more sensitive for diagnosis in these cases, poten-
tially leading to earlier diagnosis and treatment.Conclusion
Cardiac tamponade as the initial presentation of cSLE is
rare. More females than males presented in this way,
and common co-existing findings included pleuritis and/
or pleural effusion, hematologic abnormalities and low
serum complement levels. Physicians must consider
cSLE in the differential diagnosis of pericarditis and cardiac
tamponade and perform appropriate testing for rheumato-
logic disease.Consent
Written informed consent was obtained from the parent
of the patient for publication of this Case Report. A copy
of the written consent is available for review by the
Editor-in-Chief of this journal.Additional file
Additional file 1: The 12-lead electrocardiogram on presentation was
notable for sinus tachycardia, low voltage (most prominent in limb leads)
and electrical alternans (most prominent in precordial leads).
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